Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Changes in Shareholders??? Equity

v3.24.4
Condensed Interim Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary Shares
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2022 [1] $ 208,893 $ (160,140) $ 48,753
Balance (in Shares) at Dec. 31, 2022 64,160,890      
Stock-based compensation 9,860 9,860
Exercise of warrants [1] 703 703
Exercise of warrants (in Shares) 1,778,464      
Issuance of ordinary shares, net issuance costs 22,496 22,496
Issuance of ordinary shares, net issuance costs (in Shares) 11,794,873      
Net loss (34,215) (34,215)
Balance at Sep. 30, 2023 [1] 241,952 (194,355) 45,597
Balance (in Shares) at Sep. 30, 2023 77,734,227      
Balance at Dec. 31, 2023 [1] 245,733 (203,640) 42,093
Balance (in Shares) at Dec. 31, 2023 77,925,095      
Stock-based compensation 12,038 12,038
Exercise of warrants [1] 204 204
Exercise of warrants (in Shares) 3,184,800      
Net loss (37,121) (37,121)
Balance at Sep. 30, 2024 [1] $ 257,975 $ (240,761) $ 17,214
Balance (in Shares) at Sep. 30, 2024 81,109,895      
[1] Represents less than $1.